Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Receptagen Ltd. -- Ignore unavailable to you. Want to Upgrade?

To: Wizzer who wrote (196)	11/27/1998 9:03:00 AM
From: jack BROSS	Read Replies (1) \| Respond to of 203

TO WISSAM AND RUSSEL. THANKS A LOT FOR responding FRIENDS . RCG LAST STRATEGY : TO SELLTHEIR LOSSSES TO SELL IN PARTS TO LIFT THE STOCK. MY POINT OF VIEW :THEY WILL BUY THE MOST OF THE STOCK IN CIRCULATION DURING THE PERIOD OF TAXES LOSSES. THEY WILLANNONCE ANOTHER TYPE OF MERGER AT THE END OF DECEMBER.THEY WILL SPLIT THE STOCK TO HAVE AN AVERAGE OF 20 MILLIONS SHARE SO THAT MAKES THE ACTUAL STOCK 0F .02 AT .08 .................WHO WILL PAY .40 .60 OR 1.00 0R 3.00 FOR THE STOCK ONLY A BIG PHARMACEUTICAL CO WHO NEEDS ALL THE RESEARCH WORK. I THINK THAT THAT WE DON'T HAVE ANY CHANCE EXCEPT THAT A BIG FISH START TO BIT . I WILL SIT ON THE PROVIDENCE ,IT HAS ALWAYS PAY ME THANKS RUS and WIS , jack bross